Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Spinal Muscular Atrophy Type 3”

51 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 51 results

Not applicableUnknownNCT05272969
What this trial is testing

Pompe & Pain - Study to Assess Nociceptive Pain in Adult Patients With Pompe Disease

Who this might be right for
Pompe Disease (Late-onset)Inclusion Body MyositisSpinal Muscular Atrophy Type 3+1 more
LMU Klinikum 95
Testing effectiveness (Phase 2)Study completedNCT03921528
What this trial is testing

An Active Treatment Study of SRK-015 in Patients With Type 2 or Type 3 Spinal Muscular Atrophy

Who this might be right for
Spinal Muscular AtrophySpinal Muscular Atrophy Type 3Spinal Muscular Atrophy Type 2+6 more
Scholar Rock, Inc. 58
Not applicableActive Not RecruitingNCT04690998
What this trial is testing

Outcome Measures and Biomarkers in a Cohort of Spinal Muscular Atrophy Type III/ IV Patients

Who this might be right for
Spinal Muscular Atrophy
Assistance Publique Hopitaux De Marseille 104
Testing effectiveness (Phase 2)Ended earlyNCT00439569
What this trial is testing

Clinical Trial of Sodium Phenylbutyrate in Children With Spinal Muscular Atrophy Types II or III

Who this might be right for
Spinal Muscular Atrophy Type IISpinal Muscular Atrophy Type III
Westat 9
Testing effectiveness (Phase 2)Study completedNCT00227266
What this trial is testing

Valproic Acid and Carnitine in Patients With Spinal Muscular Atrophy

Who this might be right for
Spinal Muscular Atrophy
University of Utah 94
Not applicableUnknownNCT05544994
What this trial is testing

The Effect of Aerobic Exercise Training in Patients With Type III Spinal Muscular Atrophy

Who this might be right for
Neuromuscular DiseasesSpinal Muscular Atrophy Type 3
Istanbul Medipol University Hospital 20
Not applicableUnknownNCT05839145
What this trial is testing

Home Monitoring of Adult Patients With SMA: a Pilot Multicenter Validation Study

Who this might be right for
Muscular Atrophy, Spinal, Type IIMuscular Atrophy, Spinal, Type III
Institut de Myologie, France 60
Not applicableActive Not RecruitingNCT05475691
What this trial is testing

Longitudinal Data Collection in Pediatric and Adult Patients With Spinal Muscular Atrophy in Latin America

Who this might be right for
Spinal Muscular Atrophy
Hospital Israelita Albert Einstein 361
Not applicableStudy completedNCT00466349
What this trial is testing

International SMA Patient Registry

Who this might be right for
Muscular Atrophy, Spinal
Indiana University School of Medicine 3,000
Not applicableActive Not RecruitingNCT03709784
What this trial is testing

Spinraza in Adult Spinal Muscular Atrophy

Who this might be right for
Spinal Muscular AtrophySpinal Muscular Atrophy Type IISpinal Muscular Atrophy Type 3
Washington University School of Medicine 148
Testing effectiveness (Phase 2)Study completedNCT00568802
What this trial is testing

A Pilot Therapeutic Trial Using Hydroxyurea in Type II and Type III Spinal Muscular Atrophy Patients

Who this might be right for
Muscular Atrophy, Spinal
Stanford University 27
Not applicableUnknownNCT03300869
What this trial is testing

Natural History of Types 2 and 3 SMA in Taiwan

Who this might be right for
Spinal Muscular Atrophy
Kaohsiung Medical University Chung-Ho Memorial Hospital 300
Not applicableLooking for participantsNCT06562283
What this trial is testing

Evaluation of the Reproducibility of a Fatigability Test Fitted to Patients With Spinal Muscular Atrophy

Who this might be right for
Spinal AmyotrophyInfantile Spinal Muscular AtrophyJuvenile Spinal Muscular Atrophy
Centre Hospitalier Universitaire de Saint Etienne 80
Not applicableStudy completedNCT04576494
What this trial is testing

Study of the Functional Effects of Nusinersen in 5q-spinal Muscular Amyotrophy Adults (SMA Type 2 or 3 Forms)

Who this might be right for
Spinal Muscular Atrophy
CHU de Reims 4
Testing effectiveness (Phase 2)Study completedNCT02227823
What this trial is testing

Safety and Efficacy Study of Pyridostigmine on Patients With Spinal Muscular Atrophy Type 3

Who this might be right for
Spinal Muscular Atrophy Type 3
Centre Hospitalier Régional de la Citadelle 4
Testing effectiveness (Phase 2)Looking for participantsNCT05794139
What this trial is testing

Safety and Efficacy of NMD670 in Ambulatory Adult Patients With Type 3 Spinal Muscular Atrophy

Who this might be right for
Spinal Muscular Atrophy
NMD Pharma A/S 54
Not applicableStudy completedNCT03878030
What this trial is testing

Effect of Nusinersen on Adults With Spinal Muscular Atrophy

Who this might be right for
Adult Spinal Muscular Atrophy
Northwell Health 12
Not applicableUnknownNCT02831296
What this trial is testing

Prospective Evaluation of Infants With Spinal Muscular Atrophy:

Who this might be right for
Spinal Muscular Atrophy
Massachusetts General Hospital 1,000
Large-scale testing (Phase 3)Active Not RecruitingNCT04042025
What this trial is testing

Long-term Follow-up Study of Patients Receiving Onasemnogene Abeparvovec-xioi

Who this might be right for
Spinal Muscular Atrophy Type ISpinal Muscular Atrophy Type IISpinal Muscular Atrophy Type III+1 more
Novartis Gene Therapies 85
Testing effectiveness (Phase 2)Study completedNCT03781479
What this trial is testing

Controlled Trial to Evaluate Amifampridine Phosphate in Spinal Muscular Atrophy Type 3 Patients

Who this might be right for
Muscular Atrophy, Spinal
Catalyst Pharmaceuticals, Inc. 13
Load More Results